Skip to main content
    F

    Femasys Inc (FEMY)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $1.12
    -0.16 (-12.50%)

    Market Cap: $11.89M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Femasys Inc (FEMY) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Femasys (FEMY) has a market cap of $11.89M. Its share count is up 8346.02% from a year earlier. It kept -614.68% of revenue as net income over the last 12 months.

    Total Valuation

    Market Cap$11.89M
    Latest price (Nov 17, 2026)$1.12

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 157.97% in the quarter ended Sep 30, 2026 and grew 179.12% a year over 2 years.

    Shares Outstanding8.66M
    Shares Change (YoY)+8346.02%
    Shares Change (QoQ)+157.97%
    Share Count Growth (2Y CAGR)+179.12%

    Valuation Ratios

    Sales and book value multiples are 4.9x and 0.4x. Its year-end P/S ranged from 8.8x to 443.8x from 2021 to 2025.

    P/S Ratio4.9x
    Forward P/S5.7x
    P/B Ratio0.4x
    P/TBV Ratio0.4x

    Valuation history and multiples

    Price Statistics

    The stock is down 93.76% over 52 weeks and trades 40.74% below its 50-day average.

    Beta (1Y)1.99
    52-Week Change-93.76%
    1-Month Change-31.29%
    3-Month Change-58.67%
    6-Month Change-84.38%
    5-Year Change-99.01%
    Total Return (1Y)-93.76%
    Total Return (3Y CAGR)-61.27%
    Total Return (5Y CAGR)-59.48%
    Return vs SPY (1Y)-103.78%
    Max Drawdown (1Y)-94.46%
    Max Drawdown (3Y)-97.48%
    Sharpe Ratio (1Y)-2.58
    Correlation with SPY (1Y)0.27
    50-Day Average$1.89
    200-Day Average$5.49
    52-Week Range$1.25 to $20.80
    RSI (14 Days)29.3
    Average Volume (20 Days)107.08K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 8.67x current liabilities, and total debt is 0.15x shareholder equity.

    Current Ratio8.67x
    Quick Ratio6.95x
    Debt / Equity0.15x
    Interest Coverage-12.77x

    Returns and Efficiency

    Return on invested capital is -39.96% and return on equity is -44.91% over the last 12 months.

    Return on Equity (ROE)-44.91%
    Return on Assets (ROA)-34.59%
    Return on Invested Capital (ROIC)-39.96%
    ROA (5Y Average)-77.25%
    Asset Turnover0.08x
    Inventory Turnover0.13x
    Receivables Turnover10.26x
    Cash Conversion Cycle1894 days

    Scores

    FEMY has an Altman Z-Score of -5.59, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-5.59
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $1.97M over the last 12 months is down 4.21% from the 12 months before.

    Revenue$1.97M
    Revenue Growth (YoY)-4.21%
    Gross Profit$1.18M
    Operating Income-$18.36M
    Pretax Income-$12.13M
    Net Income-$12.14M
    EBITDA-$10.83M
    Reported EPS (TTM)-$3.52

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 77.03% of the $35.09M in total assets.

    Cash and Equivalents$23.91M
    Total Debt$4.01M
    Net Cash$19.90M
    Net Cash Per Share$2.30
    Working Capital$27.61M
    Shareholder Equity$27.03M
    Book Value Per Share$3.12
    Tangible Book Value$26.93M
    Tangible Book Per Share$3.11
    Total Assets$35.09M
    Total Liabilities$8.06M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $245.89K of capital spending, operating cash flow left -$17.33M of free cash flow.

    Operating Cash Flow-$17.08M
    Capital Expenditures$245.89K
    Free Cash Flow-$17.33M
    FCF Per Share-$2.07
    Depreciation and Amortization$1.57M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -929.87%.

    Gross Margin59.91%
    Operating Margin-929.87%
    Pretax Margin-614.36%
    Net Margin-614.68%
    EBITDA Margin-548.68%
    FCF Margin-877.49%
    Gross Margin (5Y Average)65.00%

    Growth

    Revenue grew 23.88% a year over 3 years.

    Revenue Growth (3Y CAGR)+23.88%
    Revenue Growth (5Y CAGR)+17.18%

    Revenue and profit by year

    Dividends and Yields

    FEMY does not pay a dividend. Its free cash flow yield is -178.64%.

    FCF Yield-178.64%
    Buyback Yield-301.56%
    Shareholder Yield-301.56%

    Stock Splits

    The last split was a 1-for-20 reverse split on Jun 8, 2026.

    Last Split DateJun 8, 2026
    Split TypeReverse split
    Split Ratio1:20

    Peer Position

    Against 10 similar companies, FEMY has the 4th highest P/S.

    P/S Ratio4.9x vs 2.7x median
    ROIC-39.96% vs 6.96% median
    Revenue Growth (Trailing 4 Quarters, YoY)-4.21% vs +3.93% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 102.86% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+102.86%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About FEMY

    What is FEMY's market cap?

    Femasys has a market cap of $11.89M.

    How many shares of FEMY are outstanding?

    Femasys has 8.66M shares outstanding. The count is up 8346.02% from a year earlier.

    Does FEMY pay a dividend?

    No. Femasys does not pay a dividend.

    How much debt does FEMY have?

    Femasys has $4.01M of total debt and $23.91M of cash and equivalents, a net cash position of $19.90M.